BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17073892)

  • 1. Current management of follicular lymphomas.
    Hiddemann W; Buske C; Dreyling M; Weigert O; Lenz G; Unterhalt M
    Br J Haematol; 2007 Jan; 136(2):191-202. PubMed ID: 17073892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment strategies in follicular lymphomas: current status and future perspectives.
    Hiddemann W; Buske C; Dreyling M; Weigert O; Lenz G; Forstpointner R; Nickenig C; Unterhalt M
    J Clin Oncol; 2005 Sep; 23(26):6394-9. PubMed ID: 16155025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of hematopoietic cell transplantation for follicular non-Hodgkin's lymphoma.
    Laport GG
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):59-65. PubMed ID: 16399587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indolent lymphomas: current and emerging treatment approaches.
    Maloney D; Kahl BS; Dreyling M
    Clin Adv Hematol Oncol; 2006 Sep; 4(9 Suppl 20):1-10; quiz 11-2. PubMed ID: 17139243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous and allogeneic stem cell transplantation in follicular lymphoma.
    Van Besien K
    Transfus Apher Sci; 2005 Feb; 32(1):45-53. PubMed ID: 15737873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell transplantation in follicular lymphoma: progress at last?
    Tse WW; Lazarus HM; Van Besien K
    Bone Marrow Transplant; 2004 Dec; 34(11):929-38. PubMed ID: 15489883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolving role of autologous and allogeneic stem cell transplantation in follicular lymphoma.
    Van Besien K
    Blood Rev; 2006 Sep; 20(5):235-44. PubMed ID: 16513231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collection of hematopoietic stem cells after previous radioimmunotherapy is feasible and does not impair engraftment after autologous stem cell transplantation in follicular lymphoma.
    Derenzini E; Stefoni V; Maglie R; Casadei B; Pellegrini C; Broccoli A; Stefani G; Fanti S; Motta MR; Narducci R; Argnani L; Zinzani PL
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1695-701. PubMed ID: 24055654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current controversies in follicular lymphoma.
    Aurora V; Winter JN
    Blood Rev; 2006 Jul; 20(4):179-200. PubMed ID: 16410034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic advances for indolent lymphomas].
    Ogura M
    Nihon Rinsho; 2000 Mar; 58(3):682-94. PubMed ID: 10741147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenance.
    Cohen Y; Solal-Céligny P; Polliack A
    Haematologica; 2003 Jul; 88(7):811-23. PubMed ID: 12857561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
    Marcus R; Hagenbeek A
    Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study.
    Sebban C; Brice P; Delarue R; Haioun C; Souleau B; Mounier N; Brousse N; Feugier P; Tilly H; Solal-Céligny P; Coiffier B
    J Clin Oncol; 2008 Jul; 26(21):3614-20. PubMed ID: 18559872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular lymphoma.
    Kang TY; Rybicki LA; Bolwell BJ; Thakkar SG; Brown S; Dean R; Sekeres MA; Advani A; Sobecks R; Kalaycio M; Pohlman B; Sweetenham JW
    Bone Marrow Transplant; 2007 Nov; 40(10):973-8. PubMed ID: 17873917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marrow-ablative treatment and autologous stem cell transplantation in follicular NHL.
    Bachy E; Salles G
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):257-70. PubMed ID: 21658622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma.
    Andersen NS; Pedersen LB; Laurell A; Elonen E; Kolstad A; Boesen AM; Pedersen LM; Lauritzsen GF; Ekanger R; Nilsson-Ehle H; Nordström M; Fredén S; Jerkeman M; Eriksson M; Väärt J; Malmer B; Geisler CH
    J Clin Oncol; 2009 Sep; 27(26):4365-70. PubMed ID: 19652064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index.
    Vose JM; Bierman PJ; Loberiza FR; Lynch JC; Bociek GR; Weisenburger DD; Armitage JO
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):36-42. PubMed ID: 18158959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiolabeled and native antibodies and the prospect of cure of follicular lymphoma.
    Buchegger F; Press OW; Delaloye AB; Ketterer N
    Oncologist; 2008 Jun; 13(6):657-67. PubMed ID: 18586921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular lymphoma: a therapeutic update.
    Italiano A; Thyss A
    Bull Cancer; 2005 Oct; 92(10):E57-64. PubMed ID: 16266867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.